Article Figures & Data
Figures
- FIGURE 1.
131I scan. High count neck and chest view of 131I whole-body scan during last recurrence obtained 72 h after oral administration of 148 MBq of 131I demonstrates no abnormal focus in neck and chest, implying palpable neck nodes are non–iodine-concentrating (a feature of dedifferentiation in thyroid carcinoma).
- FIGURE 2.
18F-FDG PET scan. Whole-body 18F-FDG PET (coronal slices) images during time of last recurrence obtained 60 min after injection of 370 MBq of 18F-FDG demonstrates multiple 18F-FDG–avid neck nodes (SUVmax, 10.3). Last slide demonstrates 18F-FDG–avid metastatic right pulmonary lesions (SUVmax, 38.1).
- FIGURE 3.
Hematoxylin and eosin sections (200×); TCV of PTC. (A) Note compactly arranged fingerlike projections with dense eosinophilic cytoplasm, overlapping nuclei, and pseudoinclusion (arrows). (B) Hematoxylin and eosin section (400×) shows papillary projections covered by tall cells (arrows).
- FIGURE 4.
BRAF mutation. (A) Sequence chromatograph of tumor showing heterozygous BRAF T1799A mutation. (B) BRAFI582M point mutation in same tissue specimen. (C) Real-time polymerase chain reaction: graph shows relative messenger RNA expression. Two-fold increase on MUC1 level is observed. (D) Semiquantitative real-time polymerase chain reaction: muc1 gene (upper) with respective β actin genes (lower).
- FIGURE 5.
Immunohistochemical detection of different tumor markers (200×): Cyclin D1 (A), galectin-3 (B), HBME1 (C), and CK19 (D).
Jump to section
Related Articles
Cited By...
- No citing articles found.